发明名称 MEDICINAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a CCR4 function control agent useful for preventing and treating diseases such as bronchial asthma and atopic dermatitis. SOLUTION: This CCR4 function control agent comprises a compound represented by formula (1) [wherein, the ring A represents a heterocyclic group; the ring B represents a carbon ring, a heterocyclic group, or the like; P<SP>1</SP>and P<SP>2</SP>are CH or N; (q) and (r) are each 0 to 2; X is -NH-, -O-, or -CH<SB>2</SB>-, or the like; Y is -CH<SB>2</SB>-, -CO-, -SO<SB>2</SB>- or the like; Z is -CO-, -SO<SB>2</SB>-, or the like; R<SP>3</SP>is a carbon cyclic group, a heterocyclic group, an hydroxy group, an alkoxy or amino] or its pharmaceutically acceptable salt. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009007341(A) 申请公布日期 2009.01.15
申请号 JP20080138903 申请日期 2008.05.28
申请人 MITSUBISHI TANABE PHARMA CORP 发明人 FURUKUBO SHIGERU;MIYAZAKI HIROSHI
分类号 A61K31/497;A61K31/501;A61K31/506;A61K31/517;A61K31/519;A61K31/52;A61K31/53;A61K31/5355;A61K31/5377;A61K31/541;A61K31/553;A61P1/04;A61P3/10;A61P7/00;A61P9/10;A61P11/00;A61P11/06;A61P13/10;A61P13/12;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P35/00;A61P35/02;A61P37/06;A61P37/08;A61P43/00;C07D237/24;C07D239/47;C07D239/48;C07D239/95;C07D241/26;C07D241/28;C07D253/06;C07D401/04;C07D401/14;C07D403/12;C07D487/04;C07D495/04;C07D498/04 主分类号 A61K31/497
代理机构 代理人
主权项
地址